Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 18Other neoplasm 1Breast 1

Conditions

Precancerous Conditions 5Tongue Neoplasms 1Rectal Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Leukoplakia, Oral 1Keratosis, Actinic 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Selenium 2alpha-Tocopherol 1Vitamin E 1Sulindac 1Rosuvastatin Calcium 1Polymerase Chain Reaction 1Mass Spectrometry 1Gene Expression Profiling 1Counseling 1Chromatography, Liquid 1Chromatography, Gas 1Cholecalciferol 1Celecoxib 1Blood Specimen Collection 1Biopsy 1Atorvastatin 1Aspirin 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Celecoxib × Other neoplasm × Clear all
NCT00685568 2018-11-07

Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis

M.D. Anderson Cancer Center

Phase 1 Completed
22 enrolled
GastrointestinalOther neoplasm

Colonic Neoplasms, Adenomatous Polyposis Coli, Precancerous Conditions, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡